Pharmafile Logo
Pharmafocus logo
Advanced Search

brexit

Showing 15 posts of 137 posts found.

imeche-logo

UK must prioritise $17bn medtech sector in face of Brexit, new report urges

May 3, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Institution of Mechanical Engineers, brexit, general election, medtech

A new report from the Institution of Mechanical Engineers (IME) has highlighted the threat Brexit poses to the $17 billion …

News
shutterstock_36423250

Trials and Tribulations: The impact of new clinical trial regulation in Europe

April 11, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, brexit, clinical trials, regulations

The clinical trial is the fulcrum on which drug development and treatment hinges. Even with the advent of new technologies …

Feature
charity_gifts_for_children_with_cancer_foundation_vanessa_isabel

Looming Brexit sparks fears for child cancer trials, experts warn

March 9, 2017
Medical Communications, Research and Development EU, ICR, brexit

The trials of cancer treatments in the EU are already at a low level and Brexit has experts worried that …

News
brexit

Brexit could delay key drugs to UK patients, ex-MHRA chairman claims

February 10, 2017
Medical Communications, Sales and Marketing Cancer, MHRA, brexit

Former UK regulator and ex-chairman of the Medicines and Healthcare products Regulatory Agency (MHRA) Sir Alasdair Breckenridge has warned that …

News
novo_flag

Novo Nordisk launches £115 million investment in UK despite Brexit

January 30, 2017
Research and Development, Sales and Marketing Novo Nordisk, University of Oxford, brexit

Novo Nordisk has given the UK a boost by confirming that it plans to go ahead with a £115 million …

News
theresa_may

PM May announces Brexit plan, BioIndustry Association CEO reacts

January 18, 2017
Research and Development, Sales and Marketing Theresa May, brexit

After months of uncertainty following the UK’s vote to leave the EU, Theresa May has finally announced the first inklings …

News
theresa_may

Theresa May promises £2 billion a year in funding for R&D

November 21, 2016
Manufacturing and Production, Medical Communications Conservative, Theresa May, brexit

The Conservative Party leader has announced a planned raise in funding for research and development for UK business to £2 …

News
c_nito_-_fotolia

UK Biopharma and life after Brexit

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit

Originally published in the September issue of Pharmafocus, Paul Ranson of global law firm Morgan Lewis’ London Life Sciences Practice …

Feature
pharmafocus_sept_2016_cover

The September issue of Pharmafocus is now live!

August 31, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myer's Squibb, Bristol-Myers Squibb, CDF, Cancer Drugs Fund, Cloud Computing, Pharmafocus, Pharmafocus new issue, brexit, clinical trial transparaency, opdivo

The latest edition of Pharmafocus is available online now. In this issue, we explore the future of the clinical trial …

News
eu_flag

UK Government commits to funding EU research projects after Brexit

August 15, 2016
Manufacturing and Production, Research and Development brexit, research

Chancellor Phillip Hammond has outlined a government commitment to guarantee EU funding for British research projects made before Britain leaves …

News
4420456374_64a3d7e6aa

Top ten stories in the pharmaceutical industry this week

August 5, 2016
Medical Communications, Research and Development Actavis, Bioelectronics, CDF, Celgne, EMA, GSK, GlaxoSmithKline, Innovate UK, Medivation, NICE, Novartis, Roche, Sanofi, Teva, appointments, apremilast, biog, breast cancer, brexit, google, pharmaceutical industry, rheumatoid arthritis, sarilumab, top ten

It’s Friday, and we’ve seen some big developments in the industry’s headlines throughout the week, from news of Glaxo-Smith-Kilne’s new …

News
brexit

The impact of Brexit on the pharmaceutical industry: some preliminary considerations

August 1, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit

The outcome of the popular vote cast on 23 June 2016 will be remembered as the start of a new …

Feature

GSK announces significant post-Brexit UK investment

July 27, 2016
Manufacturing and Production, Research and Development GSK, UK, brexit, investment

GlaxoSmithKline has given the UK life sciences industry a major boost in the post-Brexit landscape with an announcement that £275 …

News
brexit

“Immediate challenges” for UK pharma post-Brexit, says ABPI

June 24, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, brexit

The UK life sciences industry has expressed dismay at the result of the EU referendum, but has pledged to work …

News
eu

EU referendum outcome will have major consequences for UK’s pharma sector – GlobalData

June 23, 2016
Medical Communications, Sales and Marketing EMA, GlobalData, Pharma sector, brexit, referendum

The outcome of today’s referendum on the UK’s continuing membership of the European Union (EU) will have major consequences for …

News

Latest content

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

May 17, 2024

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

May 17, 2024

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024